These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2192715

  • 1. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
    Sugiyama Y, Shimura Y, Ikeda H.
    Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
    [Abstract] [Full Text] [Related]

  • 2. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T.
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [Abstract] [Full Text] [Related]

  • 3. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T.
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [Abstract] [Full Text] [Related]

  • 4. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [Abstract] [Full Text] [Related]

  • 5. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
    Hayakawa T, Shiraki T, Morimoto T, Shii K, Ikeda H.
    Biochem Biophys Res Commun; 1996 Jun 14; 223(2):439-44. PubMed ID: 8670300
    [Abstract] [Full Text] [Related]

  • 6. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H, Takeshita S, Yamamoto T, Mabuchi M, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Ita M, Mutoh S.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):182-90. PubMed ID: 16039648
    [Abstract] [Full Text] [Related]

  • 7. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY, Shen ZF, Chen YT, Sun SJ, Liu Q, Xie MZ.
    Acta Pharmacol Sin; 2005 May 05; 26(5):575-80. PubMed ID: 15842776
    [Abstract] [Full Text] [Related]

  • 8. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
    Kazumi T, Hirano T, Odaka H, Ebara T, Amano N, Hozumi T, Ishida Y, Yoshino G.
    Diabetes; 1996 Jun 05; 45(6):806-11. PubMed ID: 8635657
    [Abstract] [Full Text] [Related]

  • 9. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
    Matsuura B, Kanno S, Minami H, Tsubouchi E, Iwai M, Matsui H, Horiike N, Onji M.
    J Gastroenterol; 2004 Jun 05; 39(4):339-45. PubMed ID: 15168245
    [Abstract] [Full Text] [Related]

  • 10. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T.
    J Clin Invest; 1998 Mar 15; 101(6):1354-61. PubMed ID: 9502777
    [Abstract] [Full Text] [Related]

  • 11. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA, Cruciani-Guglielmacci C, Kassis N, Clément L, Ouali F, Caüzac M, Lebègue N, Berthelot P, Caignard DH, Pégorier JP, Renard P, Dacquet C, Ktorza A, Magnan C, Consortium of the French Ministry of Research and Technology.
    Eur J Pharmacol; 2009 Apr 17; 608(1-3):104-11. PubMed ID: 19250932
    [Abstract] [Full Text] [Related]

  • 12. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK, van de Werve G, Giacca A.
    Am J Physiol Endocrinol Metab; 2003 Feb 17; 284(2):E281-90. PubMed ID: 12531742
    [Abstract] [Full Text] [Related]

  • 13. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug 17; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 14. Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization.
    Igarashi M, Takeda Y, Ishibashi N, Takahashi K, Mori S, Tominaga M, Saito Y.
    Horm Metab Res; 1997 Sep 17; 29(9):444-9. PubMed ID: 9370113
    [Abstract] [Full Text] [Related]

  • 15. The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice.
    Moritoh Y, Takeuchi K, Asakawa T, Kataoka O, Odaka H.
    Eur J Pharmacol; 2009 Jan 14; 602(2-3):448-54. PubMed ID: 19038243
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.
    Diabetes Obes Metab; 2007 Nov 14; 9(6):879-88. PubMed ID: 17924870
    [Abstract] [Full Text] [Related]

  • 17. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H, Kim T, Lam TK, Yoshii H, Klement P, Williams W, Kawamori R, Giacca A.
    Metabolism; 2005 Sep 14; 54(9):1250-8. PubMed ID: 16125538
    [Abstract] [Full Text] [Related]

  • 18. Pioglitazone: beyond glucose control.
    de Pablos-Velasco P.
    Expert Rev Cardiovasc Ther; 2010 Aug 14; 8(8):1057-67. PubMed ID: 20670183
    [Abstract] [Full Text] [Related]

  • 19. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
    Hofmann CA, Edwards CW, Hillman RM, Colca JR.
    Endocrinology; 1992 Feb 14; 130(2):735-40. PubMed ID: 1733721
    [Abstract] [Full Text] [Related]

  • 20. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver.
    Ye JM, Frangioudakis G, Iglesias MA, Furler SM, Ellis B, Dzamko N, Cooney GJ, Kraegen EW.
    Endocrinology; 2002 Dec 14; 143(12):4527-35. PubMed ID: 12446579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.